KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Goodwill (2018 - 2025)

BioNTech SE's Goodwill history spans 8 years, with the latest figure at $428.3 million for Q4 2025.

  • On a quarterly basis, Goodwill rose 5.3% to $428.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $428.3 million, a 5.3% increase, with the full-year FY2025 number at $415.7 million, up 2.2% from a year prior.
  • Goodwill hit $428.3 million in Q4 2025 for BioNTech SE, up from $418.2 million in the prior quarter.
  • Over the last five years, Goodwill for BNTX hit a ceiling of $428.3 million in Q4 2025 and a floor of $62.4 million in Q4 2022.
  • Historically, Goodwill has averaged $349.1 million across 5 years, with a median of $400.8 million in 2024.
  • Biggest five-year swings in Goodwill: dropped 5.57% in 2022 and later skyrocketed 524.65% in 2023.
  • Tracing BNTX's Goodwill over 5 years: stood at $66.1 million in 2021, then decreased by 5.57% to $62.4 million in 2022, then skyrocketed by 524.65% to $390.0 million in 2023, then increased by 4.28% to $406.7 million in 2024, then increased by 5.3% to $428.3 million in 2025.
  • Business Quant data shows Goodwill for BNTX at $428.3 million in Q4 2025, $418.2 million in Q3 2025, and $412.1 million in Q2 2025.